XML 111 R40.htm IDEA: XBRL DOCUMENT

Statutory Information (Tables)

12 Months Ended

Dec. 31, 2019

Summary of amounts disclosed under statutory accounting practices

The statutory net income loss, policyholders' surplus and contingency reserve liability of the insurance subsidiaries of our holding company are show in table 14.1 below. The surplus amounts included in the following table are the combined policyholders' surplus of our insurance operations as utilized in our risk-to-capital calculations.



Statutory financial information of holding company and insurance subsidiaries
Table	14.1
		As of and for the Years Ended December 31,
(In thousands)		2019		2018		2017
Statutory net income		$	305,857	$	375,484	$	310,776
Statutory policyholders' surplus		1,619,069		1,683,058		1,622,115
Contingency reserve		3,021,055		2,442,996		1,896,701

For the years ended December 31, 2019, 2018, and 2017 there were no surplus contributions made to MGIC or distributions from other insurance subsidiaries to us. Dividends paid by MGIC are shown in table 14.2 below.



Surplus contributions and dividends of insurance subsidiaries
Table	14.2
		Years Ended December 31,
(In thousands)		2019		2018	2017
Dividends paid by MGIC to the parent company		$	280,000	220,000	140,000

- Definition

Tabular disclosure of how the entity's reporting under GAAP as of the balance sheet date differs from the results based on prescribed and permitted accounting practices of the state or country of domicile in which a relevant statutory filing is made, or differences in results based on the National Association of Insurance Commissioners (NAIC) prescribed practices, or a combination thereof. Describes the accounting practices used and the related monetary effect on statutory surplus, net income, and risk-based capital. If an insurance enterprise's risk-based capital would have triggered a regulatory event had it not used a permitted practice, that fact is disclosed in the financial statements. Permitted statutory accounting practices include practices not prescribed but allowed by the domiciliary state insurance department regulatory authority.

+ References + Details